STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies...

Related Keywords

Australia ,Cambridge ,Cambridgeshire ,United Kingdom ,Melbourne ,Victoria ,Oliver Rausch ,Mark Dawson ,Jerry Mcmahon ,Andrewa Guirguis ,Peter Mac ,Josefin Beate Holz ,Peter Maccallum Cancer Centre ,Therapeutics Ltd ,Utokyo Innovation Platform Co Ltd ,Taiho Ventures ,Cambridge Innovation Capital ,Fast Track Initiative ,Ip Group ,Seroba Life Sciences ,Professor Mark Dawson ,Chief Scientific Officer ,Beate Holz ,Chief Medical Officer ,Chief Executive Officer ,Yaara Ofir Rosenfeld ,Cancer Discovery ,Pfizer Ventures ,Cambridge Innovation Capitali Limited ,Maccallum Cancer Centre ,Storm Therapeutics ,